Βιογραφικό

Στρατής Κολυμπιανάκης

MD MSc (Res) MSc (HCM) PhD

Καθηγητής Μαιευτικής Γυναικολογίας και Υποβοηθούμενης Αναπαραγωγής

Ιατρική Σχολή, Αριστοτέλειο Πανεπιστήμιο Θεσσαλονίκης

Ο Στρατής Κολυμπιανάκης αποφοίτησε από την Ιατρική Σχολή του Αριστοτέλειου Πανεπιστημίου Θεσσαλονίκης το 1991 και στη συνέχεια ειδικεύθηκε στην Μαιευτική - Γυναικολογία στο Λονδίνο. Μετά την απόκτηση του τίτλου Μαιευτικής Γυναικολογίας το 2000, μετεκπαιδεύθηκε στην Ιατρική της Αναπαραγωγής στο κέντρο Αναπαραγωγικής Ιατρικής του Ελευθέρου Πανεπιστημίου Βρυξελλών από το 2000 έως το 2005, αποκτώντας μεγάλη εμπειρία στην υπογονιμότητα και στην υποβοηθούμενη αναπαραγωγή.
Το Ελεύθερο Πανεπιστήμιο Βρυξελών του απένειμε τον τίτλο του Master στην Ιατρική και Φαρμακευτική Έρευνα και της Διδακτορικής Διατριβής στη βελτιστοποίηση της διέγερσης των ωοθηκών με ανταγωνιστές.
Το 2005, μετά από οκτώ χρόνια στο εξωτερικό, επέστρεψε στην Ελλάδα, στην Ιατρική Σχολή του Αριστοτέλειου Πανεπιστημίου Θεσσαλονίκης, όπου σήμερα είναι καθηγητής Μαιευτικής Γυναικολογίας και Υποβοηθούμενης Αναπαραγωγής.

Ο Στρατής Κολυμπιανάκης είναι από τους πιο γνωστούς ειδικούς στο χώρο της αναπαραγωγής τόσο στην Ελλάδα όσο και στο εξωτερικό. Ασχολείται ενεργά με την αντιμετώπιση της υπογονιμότητας για πάνω από 20 έτη και η ακαδημαϊκή του θέση του επιτρέπει να βρίσκεται στην πρωτοπορία των εξελίξεων στο χώρο της αναπαραγωγής, με δυνατότητα άμεσης εφαρμογή τους στην κλινική πράξη για την αντιμετώπιση της υπογονιμότητας.
Η διεθνής του αναγνώριση βασίζεται τόσο στις ακαδημαϊκές του επιδόσεις όσο και στην πρακτική κλινική του προσέγγιση που εστιάζεται στην αποτελεσματική και ασφαλή αντιμετώπιση του υπογόνιμου ζευγαριού. Το επιστημονικό του ενδιαφέρον εστιάζεται στην ενδοκρινολογία της αναπαραγωγής, στις διαταραχές της γυναικείας γονιμότητας και στην διέγερση των ωοθηκών για εξωσωματική γονιμοποίηση.

Ο Στρατής Κολυμπιανάκης ασκεί έντονη εκπαιδευτική δραστηριότητα τόσο σε προπτυχιακό όσο και σε μεταπτυχιακό επίπεδο στην Ιατρική Σχολή του Αριστοτέλειου Πανεπιστημίου Θεσσαλονίκης.
Είναι Διευθυντής του Μεταπτυχιακού της Ιατρικής Σχολής «Ανθρώπινη Αναπαραγωγή» στα πλαίσια του οποίου εκπαιδεύει νέους συναδέλφους στην αντιμετώπιση της υπογονιμότητας.
Είναι επίσης διευθυντής της Μονάδας Ανθρώπινης Αναπαραγωγής στο νοσοκομείο Παπαγεωργίου, που είναι αναγνωρισμένη ως κέντρο εκπαίδευσης στην Ιατρική της Αναπαραγωγής από την Ευρωπαϊκή Εταιρεία Ανθρώπινης Αναπαραγωγής και Εμβρυολογίας (ESHRE) και το Ευρωπαϊκό Κολλέγιο Μαιευτήρων Γυναικολόγων.

Έχει υπηρετήσει ως συντονιστής της ομάδας ειδικού ενδιαφέροντος «Ενδοκρινολογία της Αναπαραγωγής» της ESHRE από το 2013 έως το 2015, οργανώνοντας πολλά σεμινάρια σε όλη την Ευρώπη στην υποβοηθούμενή αναπαραγωγή. Από το 2015 έως σήμερα είναι στο προεδρείο των ομάδων ειδικού ενδιαφέροντος της ESHRE, επιβλέποντας όλες τις εκπαιδευτικές δραστηριότητες της Εταιρείας.

Έχει δώσει πάνω από 200 διαλέξεις σε διεθνή συνέδρια και είναι στην εκδοτική ομάδα των πιο σημαντικών περιοδικών υπογονιμότητας, όπως το Human Reproduction (2005-2009), το RBMOnline (2009-present), το Fertility-Sterility (2011-present), το BJOG (2017-2020) και F&S Science (2020- today).

Ο Στρατής Κολυμπιανάκης έχει τιμηθεί από το Αριστοτέλειο Πανεπιστήμιο το 2008 με το Βραβείο Αριστείας στον τομέα της υγείας, και τα έτη 2015, 2017, 2018 με το Βραβείο Αριστείας στην έρευνα. Έχει τιμηθεί με βραβεία για επιστημονικές εργασίες σε διεθνή συνέδρια και έχει βραβευθεί για την προσφορά του ως κριτής στα δύο μεγαλύτερα επιστημονικά περιοδικά στο χώρο της υπογονιμότητας το Human Reproduction και το Fertility Sterility. Είναι επισκέπτης Καθηγητής, στο Πανεπιστήμιο Shadong στην Κίνα από το 2004.

Ο Στρατής Κολυμπιανάκης έχει διεθνή φήμη στον τομέα της Αναπαραγωγής έχοντας δημοσιεύσει πάνω από 165 επιστημονικά άρθρα σε έγκριτα διεθνή περιοδικά υπογονιμότητας και περισσότερα από 20 κεφάλαια σε βιβλία σχετικά με την υπογονιμότητα. Είναι συνεκδότης του συγγράμματος αναφοράς «Recurrent Implantation Failure” («επαναλαμβανόμενες αποτυχίες εμφύτευσης»), ένα θέμα στο οποίο έχει ειδικό ενδιαφέρον για πολλά χρόνια.
Είναι επίσης γνωστός στο διεθνή χώρο της υπογονιμότητας για την ερευνητική του ενασχόληση σχετικά με το βέλτιστο τρόπο αντιμετώπισης γυναικών με μικρό αριθμό ωαρίων και την απλοποίηση της διέγερσης των ωοθηκών με στόχο την ασφάλεια της γυναίκας και την αποτελεσματικότητα.
Ήταν μέλος της ομάδας της Ευρωπαϊκής Εταιρείας Ανθρώπινης Αναπαραγωγής και Εμβρυολογίας που εξέδωσε το 2019 τις κατευθυντήριες οδηγίες για την διέγερση των ωοθηκών για εξωσωματική γονιμοποίηση, που διαμορφώνουν το σύγχρονο τοπίο στην άσκηση της ιατρικής της αναπαραγωγής
Το επιστημονικό του έργο είναι πρώτο σε απήχηση (αριθμό αναφορών) μεταξύ των εν ενεργεία καθηγητών Μαιευτικής Γυναικολογίας της Ιατρικής Σχολής του Αριστοτέλειου Πανεπιστημίου Θεσσαλονίκης.

Δημοσιεύσεις

Διεθνή περιοδικά υπογονιμότητας

1991-1995

Tarlatzis BC, Bontis J, Kolibianakis EM, Sanopoulou T, Papadimas J, Lagos S and Mantalenakis S. Evaluation of intrauterine insemination with washed spermatozoa from the husband in the treatment of infertility. Human reproduction 1991; 6:1241-1246.

Kolibianakis EM, Tarlatzis BC, Bontis J, Papadimas J, Spanos E and Mantalenakis S. Evaluation of Hamilton-Thorn automated semen analysis system. Archives of andrology 1992; 28:213-222.

Tarlatzis BC, Danglis J, Kolibianakis EM, Papadimas J, Bontis J, Lagos S and Mantalenakis S. Effect of follicular fluid on the kinetics of human sperm acrosome reaction in vitro. Archives of andrology 1993; 31:167-175.

Tarlatzis BC, Kolibianakis EM, Bontis J, Tousiou M, Lagos S and Mantalenakis S. Effect of pentoxifylline on human sperm motility and fertilizing capacity. Archives of andrology 1995; 34:33-42.x

2002-2005

Kolibianakis EM and Devroey P. The luteal phase after ovarian stimulation. Reproductive biomedicine online 2002; 5 Suppl 1:26-35.

Tarlatzis BC and Kolibianakis EM. Direct ovarian effects and safety aspects of GnRH agonists and antagonists. Reproductive biomedicine online 2002; 5 Suppl 1:8-13.

Kolibianakis EM and Devroey P. Blastocyst culture: facts and fiction. Reproductive biomedicine online 2002; 5:285-293.

Kolibianakis E, Bourgain C, Albano C, Osmanagaoglu K, Smitz J, Van Steirteghem A and Devroey P. Effect of ovarian stimulation with recombinant follicle-stimulating hormone, gonadotropin releasing hormone antagonists, and human chorionic gonadotropin on endometrial maturation on the day of oocyte pick-up. Fertility and sterility 2002; 78:1025-1029.

Osmanagaoglu K, Collins J, Kolibianakis E, Tournaye H, Camus M, Van Steirteghem A and Devroey P. Spontaneous pregnancies in couples who discontinued intracytoplasmic sperm injection treatment: a 5-year follow-up study. Fertility and sterility 2002; 78:550-556.

Kolibianakis E, Osmanagaoglu K, Camus M, Tournaye H, Van Steirteghem A and Devroey P. Effect of repeated assisted reproductive technology cycles on ovarian response. Fertility and sterility 2002; 77:967-970.

Osmanagaoglu K, Tournaye H, Kolibianakis E, Camus M, Van Steirteghem A and Devroey P. Cumulative delivery rates after ICSI in women aged >37 years. Human reproduction 2002; 17:940-944.

Osmanagaoglu K, Kolibianakis E, Tournaye H and Devroey P. Estimation of spontaneous pregnancies in patients after unsuccessful ICSI treatment. Human reproduction 2002; 17:250-251.

Fatemi HM, Kolibianakis E, Tournaye H, Camus M, Van Steirteghem AC and Devroey P. Clomiphene citrate versus letrozole for ovarian stimulation: a pilot study. Reproductive biomedicine online 2003; 7:543-546.

Kolibianakis EM, Albano C, Camus M, Tournaye H, Van Steirteghem AC and Devroey P. Initiation of gonadotropin-releasing hormone antagonist on day 1 as compared to day 6 of stimulation: effect on hormonal levels and follicular development in in vitro fertilization cycles. The Journal of clinical endocrinology and metabolism 2003; 88:5632-5637.

Zikopoulos KA, Kolibianakis EM, Tournaye H, de Munck L, Devroey P and Camus M. Hysteroscopic septum resection using the Versapoint system in subfertile women. Reproductive biomedicine online 2003; 7:365-367.

Kolibianakis E, Zikopoulos K, Albano C, Camus M, Tournaye H, Van Steirteghem A and Devroey P. Reproductive outcome of polycystic ovarian syndrome patients treated with GnRH antagonists and recombinant FSH for IVF/ICSI. Reproductive biomedicine online 2003; 7:313-318.

Kolibianakis EM, Albano C, Camus M, Tournaye H, Van Steirteghem AC and Devroey P. Relationship between LH and oestradiol in IVF cycles before GnRH antagonist initiation. Reproductive biomedicine online 2003; 7:190-193.

Kolibianakis EM, Zikopoulos K and Devroey P. Implantation potential and clinical impact of cryopreservation--a review. Placenta 2003; 24 Suppl B:S27-33.

Osmanagaoglu K, Vernaeve V, Kolibianakis E, Tournaye H, Camus M, Van Steirteghem A and Devroey P. Cumulative delivery rates after ICSI treatment cycles with freshly retrieved testicular sperm: a 7-year follow-up study. Human reproduction 2003; 18:1836-1840.

Kolibianakis EM, Bourgain C, Platteau P, Albano C, Van Steirteghem AC and Devroey P. Abnormal endometrial development occurs during the luteal phase of nonsupplemented donor cycles treated with recombinant follicle-stimulating hormone and gonadotropin-releasing hormone antagonists. Fertility and sterility 2003; 80:464-466.

Kolibianakis EM, Albano C, Kahn J, Camus M, Tournaye H, Van Steirteghem AC and Devroey P. Exposure to high levels of luteinizing hormone and estradiol in the early follicular phase of gonadotropin-releasing hormone antagonist cycles is associated with a reduced chance of pregnancy. Fertility and sterility 2003; 79:873-880.

Kolibianakis E, Osmanagaoglu K, De Catte L, Camus M, Bonduelle M, Liebaers I, Van Steirteghem A and Devroey P. Prenatal genetic testing by amniocentesis appears to result in a lower risk of fetal loss than chorionic villus sampling in singleton pregnancies achieved by intracytoplasmic sperm injection. Fertility and sterility 2003; 79:374-378.

Kolibianakis EM, Tournaye H, Osmanagaoglu K, Camus M, Van Waesberghe L, Van Steirteghem A and Devroey P. Outcome for donors and recipients in two egg-sharing policies. Fertility and sterility 2003; 79:69-73.

Kolibianakis EM. [Optimizing ovarian stimulation for IVF using GnRH antagonists]. Journal de gynecologie, obstetrique et biologie de la reproduction 2004; 33:3S42-45.
Kolibianakis E, Albano C, Zikopoulos K, Kahn JA, Van Steirteghem A and Devroey P. GnRH antagonists in poor responders. Acta obstetricia et gynecologica Scandinavica 2004; 83:1216-1217.

Kolibianakis E, Bourgain C and Devroey P. Limits of agreement? Fertility and sterility 2004; 82:1475-1476; author reply 1476-1477.

Kolibianakis E, Zikopoulos K, Camus M, Tournaye H, Van Steirteghem A and Devroey P. Modified natural cycle for IVF does not offer a realistic chance of parenthood in poor responders with high day 3 FSH levels, as a last resort prior to oocyte donation. Human reproduction 2004; 19:2545-2549.

Kosmas IP, Kolibianakis EM and Devroey P. Association of estradiol levels on the day of hCG administration and pregnancy achievement in IVF: a systematic review. Human reproduction 2004; 19:2446-2453.

Devroey P and Kolibianakis E. Is addressing the needs of its membership an easy task for the American Society for Reproductive Medicine? Fertility and sterility 2004; 82:555-556.

Kolibianakis EM, Zikopoulos K, Schiettecatte J, Smitz J, Tournaye H, Camus M, Van Steirteghem AC and Devroey P. Profound LH suppression after GnRH antagonist administration is associated with a significantly higher ongoing pregnancy rate in IVF. Human reproduction 2004; 19:2490-2496.

Kolibianakis EM, Zikopoulos K, Verpoest W, Camus M, Joris H, Van Steirteghem AC and Devroey P. Should we advise patients undergoing IVF to start a cycle leading to a day 3 or a day 5 transfer? Human reproduction 2004; 19:2550-2554.

Kolibianakis EM and Devroey P. No decrease occurs in the number of COCs retrieved with repeated IVF cycles. Human reproduction 2004; 19:1927-1928.

Kolibianakis EM, Zikopoulos K, Smitz J, Camus M, Tournaye H, Van Steirteghem AC and Devroey P. Administration of gonadotropin-releasing hormone antagonist from day 1 of stimulation in in vitro fertilization. Fertility and sterility 2004; 82:223-226.

Kolibianakis EM, Albano C, Camus M, Tournaye H, Van Steirteghem AC and Devroey P. Prolongation of the follicular phase in in vitro fertilization results in a lower ongoing pregnancy rate in cycles stimulated with recombinant follicle-stimulating hormone and gonadotropin-releasing hormone antagonists. Fertility and sterility 2004; 82:102-107.

Zikopoulos K, Kolibianakis EM and Devroey P. Ovarian stimulation for in vitro fertilization in patients with endometriosis. Acta obstetricia et gynecologica Scandinavica 2004; 83:651-655.

Zikopoulos KA, Kolibianakis EM, Platteau P, de Munck L, Tournaye H, Devroey P and Camus M. Live delivery rates in subfertile women with Asherman's syndrome after hysteroscopic adhesiolysis using the resectoscope or the Versapoint system. Reproductive biomedicine online 2004; 8:720-725.

Kolibianakis EM, Zikopoulos K, Smitz J, Camus M, Tournaye H, Van Steirteghem AC and Devroey P. Elevated progesterone at initiation of stimulation is associated with a lower ongoing pregnancy rate after IVF using GnRH antagonists. Human reproduction 2004; 19:1525-1529.

Osmanagaoglu K, Kolibianakis E, Tournaye H, Camus M, Van Steirteghem A and Devroey P. Cumulative live birth rates after transfer of cryopreserved ICSI embryos. Reproductive biomedicine online 2004; 8:344-348.

Zikopoulos K, Kolibianakis EM, Camus M, Tournaye H, Van den Abbeel E, Joris H, Van Steirteghem A and Devroey P. Duration of gonadotropin-releasing hormone antagonist administration does not affect the outcome of subsequent frozen-thawed cycles. Fertility and sterility 2004; 81:473-475.

Kolibianakis EM, Zikopoulos KA, Fatemi HM, Osmanagaoglu K, Evenpoel J, Van Steirteghem A and Devroey P. Endometrial thickness cannot predict ongoing pregnancy achievement in cycles stimulated with clomiphene citrate for intrauterine insemination. Reproductive biomedicine online 2004; 8:115-118.

Zikopoulos K, Platteau P, Kolibianakis E, Albano C, Van Steirteghem A and Devroey P. Quintuplet pregnancy following transfer of two blastocysts: Case report. Human reproduction 2004; 19:325-327.

Kolibianakis EM, Schultze-Mosgau A, Schroer A, van Steirteghem A, Devroey P, Diedrich K and Griesinger G. A lower ongoing pregnancy rate can be expected when GnRH agonist is used for triggering final oocyte maturation instead of HCG in patients undergoing IVF with GnRH antagonists. Human reproduction 2005; 20:2887-2892.

Kolibianakis EM, Tarlatzis B and Devroey P. GnRH antagonists in IVF. Reproductive biomedicine online 2005; 10:705-712.

Papanikolaou EG, Vernaeve V, Kolibianakis E, Assche EV, Bonduelle M, Liebaers I, Van Steirteghem A and Devroey P. Is chromosome analysis mandatory in the initial investigation of normovulatory women seeking infertility treatment? Human reproduction 2005; 20:2899-2903.

Papanikolaou EG, Kolibianakis E and Devroey P. Emerging drugs in assisted reproduction. Expert opinion on emerging drugs 2005; 10:425-440.

Kolibianakis EM, Bourgain C, Papanikolaou EG, Camus M, Tournaye H, Van Steirteghem AC and Devroey P. Prolongation of follicular phase by delaying hCG administration results in a higher incidence of endometrial advancement on the day of oocyte retrieval in GnRH antagonist cycles. Human reproduction 2005; 20:2453-2456.

Kolibianakis EM, Papanikolaou EG, Fatemi HM and Devroey P. Estrogen and folliculogenesis: is one necessary for the other? Current opinion in obstetrics & gynecology 2005; 17:249-253.

Papanikolaou EG, Platteau P, Albano C, Kolibianakis E and Devroey P. Achievement of pregnancy three times in the same patient during luteal GnRH agonist administration. Reproductive biomedicine online 2005; 10:347-349.

Papanikolaou EG, Bourgain C, Kolibianakis E, Tournaye H and Devroey P. Steroid receptor expression in late follicular phase endometrium in GnRH antagonist IVF cycles is already altered, indicating initiation of early luteal phase transformation in the absence of secretory changes. Human reproduction 2005; 20:1541-1547.

2006-2009

Fatemi HM, Kolibianakis EM, Camus M, Tournaye H, Donoso P, Papanikolaou E and Devroey P. Addition of estradiol to progesterone for luteal supplementation in patients stimulated with GnRH antagonist/rFSH for IVF: a randomized controlled trial. Human reproduction 2006; 21:2628-2632.

Griesinger G, Diedrich K, Devroey P and Kolibianakis EM. GnRH agonist for triggering final oocyte maturation in the GnRH antagonist ovarian hyperstimulation protocol: a systematic review and meta-analysis. Human reproduction update 2006; 12:159-168.

Griesinger G, Diedrich K, Tarlatzis BC and Kolibianakis EM. GnRH-antagonists in ovarian stimulation for IVF in patients with poor response to gonadotrophins, polycystic ovary syndrome, and risk of ovarian hyperstimulation: a meta-analysis. Reproductive biomedicine online 2006; 13:628-638.

Kolibianakis EM, Collins J, Tarlatzis B, Papanikolaou E and Devroey P. Are endogenous LH levels during ovarian stimulation for IVF using GnRH analogues associated with the probability of ongoing pregnancy? A systematic review. Human reproduction update 2006; 12:3-12.

Kolibianakis EM, Collins J, Tarlatzis BC, Devroey P, Diedrich K and Griesinger G. Among patients treated for IVF with gonadotrophins and GnRH analogues, is the probability of live birth dependent on the type of analogue used? A systematic review and meta-analysis. Human reproduction update 2006; 12:651-671.

Kolibianakis EM, Papanikolaou EG, Camus M, Tournaye H, Van Steirteghem AC and Devroey P. Menstruation-free interval and ongoing pregnancy in IVF using GnRH antagonists. Human reproduction 2006; 21:1012-1017.

Kolibianakis EM, Papanikolaou EG, Camus M, Tournaye H, Van Steirteghem AC and Devroey P. Effect of oral contraceptive pill pretreatment on ongoing pregnancy rates in patients stimulated with GnRH antagonists and recombinant FSH for IVF. A randomized controlled trial. Human reproduction 2006; 21:352-357.

Papanikolaou EG, Camus M, Kolibianakis EM, Van Landuyt L, Van Steirteghem A and Devroey P. In vitro fertilization with single blastocyst-stage versus single cleavage-stage embryos. The New England journal of medicine 2006; 354:1139-1146.

Papanikolaou EG, Pozzobon C, Kolibianakis EM, Camus M, Tournaye H, Fatemi HM, Van Steirteghem A and Devroey P. Incidence and prediction of ovarian hyperstimulation syndrome in women undergoing gonadotropin-releasing hormone antagonist in vitro fertilization cycles. Fertility and sterility 2006; 85:112-120.

Tarlatzis BC, Fauser BC, Kolibianakis EM, Diedrich K, Rombauts L and Devroey P. GnRH antagonists in ovarian stimulation for IVF. Human reproduction update 2006; 12:333-340.

Verpoest WM, Kolibianakis E, Papanikolaou E, Smitz J, Van Steirteghem A and Devroey P. Aromatase inhibitors in ovarian stimulation for IVF/ICSI: a pilot study. Reproductive biomedicine online 2006; 13:166-172.

Fatemi HM, Camus M, Kolibianakis EM, Tournaye H, Papanikolaou EG, Donoso P and Devroey P. The luteal phase of recombinant follicle-stimulating hormone/gonadotropin-releasing hormone antagonist in vitro fertilization cycles during supplementation with progesterone or progesterone and estradiol. Fertility and sterility 2007; 87:504-508.

Griesinger G, Kolibianakis EM, Papanikolaou EG, Diedrich K, Van Steirteghem A, Devroey P, Ejdrup Bredkjaer H and Humaidan P. Triggering of final oocyte maturation with gonadotropin-releasing hormone agonist or human chorionic gonadotropin. Live birth after frozen-thawed embryo replacement cycles. Fertility and sterility 2007; 88:616-621.

Griesinger G, Weig M, Schroer A, Diedrich K and Kolibianakis EM. Mid-cycle serum levels of endogenous LH are not associated with the likelihood of pregnancy in artificial frozen-thawed embryo transfer cycles without pituitary suppression. Human reproduction 2007; 22:2589-2593.

Kolibianakis EM, Kalogeropoulou L, Griesinger G, Papanikolaou EG, Papadimas J, Bontis J and Tarlatzis BC. Among patients treated with FSH and GnRH analogues for in vitro fertilization, is the addition of recombinant LH associated with the probability of live birth? A systematic review and meta-analysis. Human reproduction update 2007; 13:445-452.

Kolibianakis EM, Papanikolaou EG, Tournaye H, Camus M, Van Steirteghem AC and Devroey P. Triggering final oocyte maturation using different doses of human chorionic gonadotropin: a randomized pilot study in patients with polycystic ovary syndrome treated with gonadotropin-releasing hormone antagonists and recombinant follicle-stimulating hormone. Fertility and sterility 2007; 88:1382-1388.

Kolibianakis EM, Venetis CA and Tarlatzis BC. The effect of oral contraceptives on assisted reproductive technology [corrected] cycles. Current opinion in obstetrics & gynecology 2007; 19:244-247.

Kosmas IP, Tatsioni A, Fatemi HM, Kolibianakis EM, Tournaye H and Devroey P. Human chorionic gonadotropin administration vs. luteinizing monitoring for intrauterine insemination timing, after administration of clomiphene citrate: a meta-analysis. Fertility and sterility 2007; 87:607-612.

Lainas TG, Petsas GK, Zorzovilis IZ, Iliadis GS, Lainas GT, Cazlaris HE and Kolibianakis EM. Initiation of GnRH antagonist on Day 1 of stimulation as compared to the long agonist protocol in PCOS patients. A randomized controlled trial: effect on hormonal levels and follicular development. Human reproduction 2007; 22:1540-1546.

Lainas TG, Sfontouris IA, Zorzovilis IZ, Petsas GK, Lainas GT and Kolibianakis EM. Management of severe early ovarian hyperstimulation syndrome by re-initiation of GnRH antagonist. Reproductive biomedicine online 2007; 15:408-412.

Tarlatzis BC and Kolibianakis EM. GnRH agonists vs antagonists. Best practice & research Clinical obstetrics & gynaecology 2007; 21:57-65.

Venetis CA, Kolibianakis EM, Papanikolaou E, Bontis J, Devroey P and Tarlatzis BC. Is progesterone elevation on the day of human chorionic gonadotrophin administration associated with the probability of pregnancy in in vitro fertilization? A systematic review and meta-analysis. Human reproduction update 2007; 13:343-355.

Griesinger G, Kolibianakis EM, Diedrich K and Ludwig M. Ovarian stimulation for IVF has no quantitative association with birthweight: a registry study. Human reproduction 2008; 23:2549-2554.

Griesinger G, Venetis CA, Marx T, Diedrich K, Tarlatzis BC and Kolibianakis EM. Oral contraceptive pill pretreatment in ovarian stimulation with GnRH antagonists for IVF: a systematic review and meta-analysis. Fertility and sterility 2008; 90:1055-1063.

Kolibianakis EM, Venetis CA, Papanikolaou EG, Diedrich K, Tarlatzis BC and Griesinger G. Estrogen addition to progesterone for luteal phase support in cycles stimulated with GnRH analogues and gonadotrophins for IVF: a systematic review and meta-analysis. Human reproduction 2008; 23:1346-1354.

Kosmas IP, Tatsioni A, Kolibianakis EM, Verpoest W, Tournaye H, Van der Elst J and Devroey P. Effects and clinical significance of GnRH antagonist administration for IUI timing in FSH superovulated cycles: a meta-analysis. Fertility and sterility 2008; 90:367-372.

Lainas TG, Sfontouris IA, Papanikolaou EG, Zorzovilis JZ, Petsas GK, Lainas GT and Kolibianakis EM. Flexible GnRH antagonist versus flare-up GnRH agonist protocol in poor responders treated by IVF: a randomized controlled trial. Human reproduction 2008; 23:1355-1358.

Loutradi KE, Kolibianakis EM, Venetis CA, Papanikolaou EG, Pados G, Bontis I and Tarlatzis BC. Cryopreservation of human embryos by vitrification or slow freezing: a systematic review and meta-analysis. Fertility and sterility 2008; 90:186-193.

Loutradi KE, Tarlatzi TB, Kolibianakis EM and Tarlatzis BC. Does hyaluronan improve embryo implantation? Current opinion in obstetrics & gynecology 2008; 20:305-307.

Papanikolaou EG, Kolibianakis EM, Tournaye H, Venetis CA, Fatemi H, Tarlatzis B and Devroey P. Live birth rates after transfer of equal number of blastocysts or cleavage-stage embryos in IVF. A systematic review and meta-analysis. Human reproduction 2008; 23:91-99.

Venetis CA, Kolibianakis EM and Tarlatzis BC. Progesterone elevation and probability of pregnancy after IVF: facts and fiction. Human reproduction update 2008; 14:538.

Devroey P, Aboulghar M, Garcia-Velasco J, Griesinger G, Humaidan P, Kolibianakis E, Ledger W, Tomas C and Fauser BC. Improving the patient's experience of IVF/ICSI: a proposal for an ovarian stimulation protocol with GnRH antagonist co-treatment. Human reproduction 2009; 24:764-774.

Kolibianakis EM, Venetis CA, Diedrich K, Tarlatzis BC and Griesinger G. Addition of growth hormone to gonadotrophins in ovarian stimulation of poor responders treated by in-vitro fertilization: a systematic review and meta-analysis. Human reproduction update 2009; 15:613-622.

Kolibianakis EM, Venetis CA and Tarlatzis BC. Role of the endocrine profile for the achievement of pregnancy with IVF. Reproductive biomedicine online 2009; 18 Suppl 2:37-43.

Kolibianakis EM, Venetis CA and Tarlatzis BC. Cryopreservation of human embryos by vitrification or slow freezing: which one is better? Current opinion in obstetrics & gynecology 2009; 21:270-274.

Kyrou D, Kolibianakis EM, Venetis CA, Miliaras D, Theodoridis T, Tzevelekis F, Bontis J and Tarlatzis BC. Steroid receptor expression in human endometrium during the follicular phase of stimulated cycles. Human reproduction 2009; 24:2931-2935.

Kyrou D, Kolibianakis EM, Venetis CA, Papanikolaou EG, Bontis J and Tarlatzis BC. How to improve the probability of pregnancy in poor responders undergoing in vitro fertilization: a systematic review and meta-analysis. Fertility and sterility 2009; 91:749-766.

Lainas TG, Sfontouris IA, Zorzovilis IZ, Petsas GK, Lainas GT, Alexopoulou E and Kolibianakis EM. Live births after management of severe OHSS by GnRH antagonist administration in the luteal phase. Reproductive biomedicine online 2009; 19:789-795.

Lainas TG, Sfontouris IA, Zorzovilis IZ, Petsas GK, Lainas GT, Iliadis GS and Kolibianakis EM. Management of severe OHSS using GnRH antagonist and blastocyst cryopreservation in PCOS patients treated with long protocol. Reproductive biomedicine online 2009; 18:15-20.

Mitsiakos G, Giougi E, Tsakalidis C, Kourti M, Chatziionnidis H, Karagianni P, Kolibianakis EM and Nikolaidis N. A case of Adams-Oliver syndrome following in vitro fertilization. Human reproduction 2009; 24:1529-1530.

Papanikolaou EG, Kolibianakis EM, Pozzobon C, Tank P, Tournaye H, Bourgain C, Van Steirteghem A and Devroey P. Progesterone rise on the day of human chorionic gonadotropin administration impairs pregnancy outcome in day 3 single-embryo transfer, while has no effect on day 5 single blastocyst transfer. Fertility and sterility 2009; 91:949-952.

Toulis KA, Goulis DG, Kolibianakis EM, Venetis CA, Tarlatzis BC and Papadimas I. Risk of gestational diabetes mellitus in women with polycystic ovary syndrome: a systematic review and a meta-analysis. Fertility and sterility 2009; 92:667-677.

Toulis KA, Goulis DG, Venetis CA, Kolibianakis EM, Tarlatzis BC and Papadimas I. Thyroid autoimmunity and miscarriages: the corpus luteum hypothesis. Medical hypotheses 2009; 73:1060-1062.

Venetis CA, Kolibianakis EM, Tarlatzi TB and Tarlatzis BC. Benefits of luteinizing hormone activity in ovarian stimulation for IVF. Reproductive biomedicine online 2009; 18 Suppl 2:31-36.

Kyrou D, Kolibianakis EM, Devroey P and Fatemi HM. Is the use of donor sperm associated with a higher incidence of preeclampsia in women who achieve pregnancy after intrauterine insemination? Fertility and sterility 2010; 93:1124-1127.

Lainas TG, Sfontouris IA, Zorzovilis IZ, Petsas GK, Lainas GT, Alexopoulou E and Kolibianakis EM. Flexible GnRH antagonist protocol versus GnRH agonist long protocol in patients with polycystic ovary syndrome treated for IVF: a prospective randomised controlled trial (RCT). Human reproduction 2010; 25:683-689.

Papanikolaou EG, Fatemi H, Venetis C, Donoso P, Kolibianakis E, Tournaye H, Tarlatzis B and Devroey P. Monozygotic twinning is not increased after single blastocyst transfer compared with single cleavage-stage embryo transfer. Fertility and sterility 2010; 93:592-597.

Toulis KA, Goulis DG, Venetis CA, Kolibianakis EM, Negro R, Tarlatzis BC and Papadimas I. Risk of spontaneous miscarriage in euthyroid women with thyroid autoimmunity undergoing IVF: a meta-analysis. European journal of endocrinology / European Federation of Endocrine Societies 2010; 162:643-652.

2010-2013

Griesinger G, Kolibianakis EM, Venetis C, Diedrich K and Tarlatzis B. Oral contraceptive pretreatment significantly reduces ongoing pregnancy likelihood in gonadotropin-releasing hormone antagonist cycles: an updated meta-analysis. Fertility and sterility 2010; 94:2382-2384.

Kyrou D, Kolibianakis EM, Devroey P and Fatemi HM. Is the use of donor sperm associated with a higher incidence of preeclampsia in women who achieve pregnancy after intrauterine insemination? Fertility and sterility 2010; 93:1124-1127.

Lainas TG, Sfontouris IA, Zorzovilis IZ, Petsas GK, Lainas GT, Alexopoulou E and Kolibianakis EM. Flexible GnRH antagonist protocol versus GnRH agonist long protocol in patients with polycystic ovary syndrome treated for IVF: a prospective randomised controlled trial (RCT). Human reproduction 2010; 25:683-689.

Papanikolaou EG, Bourgain C, Fatemi H, Verpoest W, Polyzos NP, De Brabanter A, Kolibianakis E, Tarlatzis B, Devroey P and Tournaye H. Endometrial advancement after triggering with recombinant or urinary HCG: a randomized controlled pilot study. Reproductive biomedicine online 2010; 21:50-55.

Papanikolaou EG, Fatemi H, Venetis C, Donoso P, Kolibianakis E, Tournaye H, Tarlatzis B and Devroey P. Monozygotic twinning is not increased after single blastocyst transfer compared with single cleavage-stage embryo transfer. Fertility and sterility 2010; 93:592-597.

Toulis KA, Goulis DG, Venetis CA, Kolibianakis EM, Negro R, Tarlatzis BC and Papadimas I. Risk of spontaneous miscarriage in euthyroid women with thyroid autoimmunity undergoing IVF: a meta-analysis. European journal of endocrinology / European Federation of Endocrine Societies 2010; 162:643-652.

Venetis CA, Kolibianakis EM, Tarlatzi TB and Tarlatzis BC. Evidence-based management of poor ovarian response. Annals of the New York Academy of Sciences 2010; 1205:199-206.

Griesinger G, Shapiro DB, Kolibianakis EM, Witjes H and Mannaerts BM. No association between endogenous LH and pregnancy in a GnRH antagonist protocol: part II, recombinant FSH. Reproductive biomedicine online 2011; 23:457-465.

Kolibianakis EM, Venetis CA, Kalogeropoulou L, Papanikolaou E and Tarlatzis BC. Fixed versus flexible gonadotropin-releasing hormone antagonist administration in in vitro fertilization: a randomized controlled trial. Fertility and sterility 2011; 95:558-562.

Kolibianakis EM, Venetis CA and Tarlatzis BC. DHEA administration in poor responders. Human reproduction 2011; 26:730-731; author reply 731.

Kyrou D, Kolibianakis EM, Fatemi HM, Camus M, Tournaye H, Tarlatzis BC and Devroey P. High exposure to progesterone between the end of menstruation and the day of triggering final oocyte maturation is associated with a decreased probability of pregnancy in patients treated by in vitro fertilization and intracytoplasmic sperm injection. Fertility and sterility 2011; 96:884-888.

Kyrou D, Kolibianakis EM, Fatemi HM, Tarlatzi TB, Devroey P and Tarlatzis BC. Increased live birth rates with GnRH agonist addition for luteal support in ICSI/IVF cycles: a systematic review and meta-analysis. Human reproduction update 2011; 17:734-740.

Kyrou D, Kolibianakis EM, Fatemi HM, Tarlatzis BC, Tournaye H and Devroey P. Is earlier administration of human chorionic gonadotropin (hCG) associated with the probability of pregnancy in cycles stimulated with recombinant follicle-stimulating hormone and gonadotropin-releasing hormone (GnRH) antagonists? A prospective randomized trial. Fertility and sterility 2011; 96:1112-1115.

Mintziori G, Goulis DG, Toulis KA, Venetis CA, Kolibianakis EM and Tarlatzis BC. Thyroid function during ovarian stimulation: a systematic review. Fertility and sterility 2011; 96:780-785.

Tarlatzis BC and Kolibianakis EM. Barriers to conducting clinical research in reproductive medicine: Greece. Fertility and sterility 2011; 96:807-808.

Van Vaerenbergh I, Fatemi HM, Blockeel C, Van Lommel L, In't Veld P, Schuit F, Kolibianakis EM, Devroey P and Bourgain C. Progesterone rise on HCG day in GnRH antagonist/rFSH stimulated cycles affects endometrial gene expression. Reproductive biomedicine online 2011; 22:263-271.

Venetis CA, Kolibianakis EM, Toulis KA, Goulis DG, Papadimas I and Tarlatzis BC. Intravenous albumin administration for the prevention of severe ovarian hyperstimulation syndrome: a systematic review and metaanalysis. Fertility and sterility 2011; 95:188-196, 196 e181-183.

Al-Azemi M, Kyrou D, Kolibianakis EM, Humaidan P, Van Vaerenbergh I, Devroey P and Fatemi HM. Elevated progesterone during ovarian stimulation for IVF. Reproductive biomedicine online 2012; 24:381-388.

Bosdou JK, Venetis CA, Kolibianakis EM, Toulis KA, Goulis DG, Zepiridis L and Tarlatzis BC. The use of androgens or androgen-modulating agents in poor responders undergoing in vitro fertilization: a systematic review and meta-analysis. Human reproduction update 2012; 18:127-145.

Griesinger G and Kolibianakis EM. Can oestradiol pretreatment be used to reliably avoid weekend oocyte retrievals? Reproductive biomedicine online 2012; 24:487-489.
Kolibianakis EM, Griesinger G and Venetis CA. GnRH agonist for triggering final oocyte maturation: time for a critical evaluation of data. Human reproduction update 2012; 18:228-229; author reply 229-230.

Kolibianakis EM, Venetis CA, Bontis J and Tarlatzis BC. Significantly lower pregnancy rates in the presence of progesterone elevation in patients treated with GnRH antagonists and gonadotrophins: a systematic review and meta-analysis. Current pharmaceutical biotechnology 2012; 13:464-470.

Kyrou D, Kolibianakis EM, Fatemi HM, Grimbizis GF, Theodoridis TD, Camus M, Tournaye H, Tarlatzis BC and Devroey P. Spontaneous triggering of ovulation versus HCG administration in patients undergoing IUI: a prospective randomized study. Reproductive biomedicine online 2012; 25:278-283.

Lainas GT, Kolibianakis EM, Sfontouris IA, Zorzovilis IZ, Petsas GK, Tarlatzi TB, Tarlatzis BC and Lainas TG. Outpatient management of severe early OHSS by administration of GnRH antagonist in the luteal phase: an observational cohort study. Reproductive biology and endocrinology : RB&E 2012; 10:69.

Griesinger G, Mannaerts B, Andersen CY, Witjes H, Kolibianakis EM and Gordon K. Progesterone elevation does not compromise pregnancy rates in high responders: a pooled analysis of in vitro fertilization patients treated with recombinant follicle-stimulating hormone/gonadotropin-releasing hormone antagonist in six trials. Fertility and sterility 2013; 100:1622-1628 e1621-1623.

Lainas GT, Kolibianakis EM, Sfontouris IA, Zorzovilis IZ, Petsas GK, Lainas TG and Tarlatzis BC. Pregnancy and neonatal outcomes following luteal GnRH antagonist administration in patients with severe early OHSS. Human reproduction 2013; 28:1929-1942.

Levy MJ, Ledger W, Kolibianakis EM, Ijzerman-Boon PC and Gordon K. Is it possible to reduce the incidence of weekend oocyte retrievals in GnRH antagonist protocols? Reproductive biomedicine online 2013; 26:50-58.

Mintziori G, Lambrinoudaki I, Kolibianakis EM, Ceausu I, Depypere H, Erel CT, Perez-Lopez FR, Schenck-Gustafsson K, van der Schouw Y, Simoncini T et al. EMAS position statement: Late parenthood. Maturitas 2013; 76:200-204.

Venetis CA, Kolibianakis EM, Bosdou JK and Tarlatzis BC. Progesterone elevation and probability of pregnancy after IVF: a systematic review and meta-analysis of over 60 000 cycles. Human reproduction update 2013; 19:433-457.

Griesinger G, Mannaerts B, Andersen CY, Witjes H, Kolibianakis EM and Gordon K. Reply of the authors. Fertility and sterility 2014; 101:e5-6.

Mastrogianni O, Gbandi E, Orphanidis A, Raikos N, Goutziomitrou E, Kolibianakis EM, Tarlatzis BC and Goulas A. Association of the CYP2B6 c.516G>T polymorphism with high blood propofol concentrations in women from northern Greece. Drug metabolism and pharmacokinetics 2014; 29:215-218.

Mintziori G, Goulis DG, Gialamas E, Dosopoulos K, Zouzoulas D, Gitas G, Venetis CA, Toulis KA, Kolibianakis EM and Tarlatzis BC. Association of TSH concentrations and thyroid autoimmunity with IVF outcome in women with TSH concentrations within normal adult range. Gynecologic and obstetric investigation 2014; 77:84-88.

2014 - σήμερα

Decleer W, Osmanagaoglu K, Seynhave B, Kolibianakis S, Tarlatzis B, Devroey P. Comparison of hCG triggering versus hCG in combination with a GnRH agonist: a prospective randomized controlled trial. Facts Views Vis Obgyn 2014;6: 203-209.

Kolibianakis S. Increasing survival of the graft: the way forward in ovarian tissue transplantation. Reprod Biomed Online 2015;30: 4-5.

Kolibianakis EM, Venetis CA, Bosdou JK, Zepiridis L, Chatzimeletiou K, Makedos A, Masouridou S, Triantafillidis S, Mitsoli A, Tarlatzis BC. Corifollitropin alfa compared with follitropin beta in poor responders undergoing ICSI: a randomized controlled trial. Hum Reprod 2015;30: 432-440.

Ganidou MA, Kolibianakis EM, Venetis CA, Gerou S, Makedos GA, Klearchou N, Tarlatzis BC. Is assessment of anti-Mullerian hormone and/or antral follicle count useful in the prediction of ovarian response in expected normal responders treated with a fixed dose of recombinant FSH and GnRH antagonists? A prospective observational study. Gynecol Endocrinol 2014;30: 817-821.

Lainas GT, Kolibianakis EM, Sfontouris IA, Zorzovilis IZ, Petsas GK, Lainas TG, Tarlatzis BC. Serum vascular endothelial growth factor levels following luteal gonadotrophin-releasing hormone antagonist administration in women with severe early ovarian hyperstimulation syndrome. BJOG 2014;121: 848-855.

Lehert P, Kolibianakis EM, Venetis CA, Schertz J, Saunders H, Arriagada P, Copt S, Tarlatzis B. Recombinant human follicle-stimulating hormone (r-hFSH) plus recombinant luteinizing hormone versus r-hFSH alone for ovarian stimulation during assisted reproductive technology: systematic review and meta-analysis. Reprod Biol Endocrinol 2014;12: 17.

Mintziori G, Goulis DG, Gialamas E, Dosopoulos K, Zouzoulas D, Gitas G, Venetis CA, Toulis KA, Kolibianakis EM, Tarlatzis BC. Association of TSH concentrations and thyroid autoimmunity with IVF outcome in women with TSH concentrations within normal adult range. Gynecol Obstet Invest 2014;77: 84-88.

Griesinger G, Mannaerts B, Andersen CY, Witjes H, Kolibianakis EM, Gordon K. Reply of the authors. Fertil Steril 2014;101: e5-6.

Mastrogianni O, Gbandi E, Orphanidis A, Raikos N, Goutziomitrou E, Kolibianakis EM, Tarlatzis BC, Goulas A. Association of the CYP2B6 c.516G>T polymorphism with high blood propofol concentrations in women from northern Greece. Drug Metab Pharmacokinet 2014;29: 215-218.

Goutziomitrou E, Venetis CA, Kolibianakis EM, Bosdou JK, Parlapani A, Grimbizis G, Tarlatzis BC. Propofol versus thiopental sodium as anaesthetic agents for oocyte retrieval: a randomized controlled trial. Reprod Biomed Online 2015;31: 752-759.

Kolibianakis EM, Lainas TG, Venetis CA. Reply: Modified natural cycles for poor responders: addressing misconceptions and fallacies. Hum Reprod 2016;31: 222-223.

Mintziori G, Goulis DG, Kolibianakis EM, Slavakis A, Bosdou J, Grimbizis G, Tarlatzis BC. Thyroid function and autoimmunity during ovarian stimulation for intracytoplasmic sperm injection. Reprod Fertil Dev 2015.

Bosdou JK, Kolibianakis EM, Venetis CA, Zepiridis L, Chatzimeletiou K, Makedos A, Triantafyllidis S, Masouridou S, Mitsoli A, Tarlatzis B. Is the time interval between HCG administration and oocyte retrieval associated with oocyte retrieval rate? Reprod Biomed Online 2015;31: 625-632.

Lainas TG, Sfontouris IA, Venetis CA, Lainas GT, Zorzovilis IZ, Tarlatzis BC, Kolibianakis EM. Live birth rates after modified natural cycle compared with high-dose FSH stimulation using GnRH antagonists in poor responders. Hum Reprod 2015;30: 2321-2330.

Griesinger G, Venetis CA, Tarlatzis B, Kolibianakis EM. To pill or not to pill in GnRH-antagonist cycles: the answer is in the data already! Reprod Biomed Online 2015;31: 6-8.

Sfontouris IA, Kolibianakis EM, Lainas GT, Navaratnarajah R, Tarlatzis BC, Lainas TG. Live birth rates using conventional in vitro fertilization compared to intracytoplasmic sperm injection in Bologna poor responders with a single oocyte retrieved. J Assist Reprod Genet 2015;32: 691-697.

Lainas TG, Kolibianakis EM. Authors' reply. BJOG 2015;122: 585-586.

Venetis CA, Kolibianakis EM, Bosdou JK, Lainas GT, Sfontouris IA, Tarlatzis BC, Lainas TG. Estimating the net effect of progesterone elevation on the day of hCG on live birth rates after IVF: a cohort analysis of 3296 IVF cycles. Hum Reprod 2015;30: 684-691.

Kolibianakis S. Increasing survival of the graft: the way forward in ovarian tissue transplantation. Reprod Biomed Online 2015;30: 4-5.

Kolibianakis EM, Venetis CA, Bosdou JK, Zepiridis L, Chatzimeletiou K, Makedos A, Masouridou S, Triantafillidis S, Mitsoli A, Tarlatzis BC. Corifollitropin alfa compared with follitropin beta in poor responders undergoing ICSI: a randomized controlled trial. Hum Reprod 2015;30: 432-440.

Oikonomou Z, Chatzimeletiou K, Sioga A, Oikonomou L, Tarlatzis BC, Kolibianakis E. Effects of vitrification on blastomere viability and cytoskeletal integrity in mouse embryos. Zygote 2017;25: 75-84.

Venetis CA, Kolibianakis EM, Bosdou JK, Lainas GT, Sfontouris IA, Tarlatzis BC, Lainas TG. Basal serum progesterone and history of elevated progesterone on the day of hCG administration are significant predictors of late follicular progesterone elevation in GnRH antagonist IVF cycles. Hum Reprod 2016;31: 1859-1865.

Bosdou JK, Kolibianakis EM, Tarlatzis BC, Fatemi HM. Sociocultural influences on fertility in the Middle East: the role of parental consanguinity, obesity and vitamin D deficiency. Fertil Steril 2016;106: 259-260.

Mintziori G, Goulis DG, Kolibianakis EM. Thyroid function and IVF outcome: when to investigate and when to intervene? Curr Opin Obstet Gynecol 2016;28: 191-197.

Bosdou JK, Venetis CA, Dafopoulos K, Zepiridis L, Chatzimeletiou K, Anifandis G, Mitsoli A, Makedos A, Messinis IE, Tarlatzis BC, Kolibianakis E.M. Transdermal testosterone pretreatment in poor responders undergoing ICSI: a randomized clinical trial. Hum Reprod 2016;31: 977-985.

Bosch E, Labarta E, Kolibianakis E, Rosen M, Meldrum D. Regimen of ovarian stimulation affects oocyte and therefore embryo quality. Fertil Steril 2016;105: 560-570.

Kolibianakis EM, Lainas TG, Venetis CA. Reply: Modified natural cycles for poor responders: addressing misconceptions and fallacies. Hum Reprod 2016;31: 222-223.

Sfontouris IA, Kolibianakis EM, Lainas GT, Petsas GK, Tarlatzis BC, Lainas TG. Blastocyst Development in a Single Medium Compared to Sequential Media. Reprod Sci 2017: 1933719116687653.

Oikonomou Z, Chatzimeletiou K, Sioga A, Oikonomou L, Tarlatzis BC, Kolibianakis E. Effects of vitrification on blastomere viability and cytoskeletal integrity in mouse embryos. Zygote 2017;25: 75-84.

Mintziori G, Goulis DG, Kolibianakis EM, Slavakis A, Bosdou J, Grimbizis G, Tarlatzis BC. Thyroid function and autoimmunity during ovarian stimulation for intracytoplasmic sperm injection. Reprod Fertil Dev 2017;29: 603-608.

Sfontouris IA, Kolibianakis EM, Lainas GT, Venetis CA, Petsas GK, Tarlatzis BC, Lainas TG. Blastocyst utilization rates after continuous culture in two commercial single-step media: a prospective randomized study with sibling oocytes. J Assist Reprod Genet 2017;34: 1377-1383.

Awaga HA, Bosdou JK, Goulis DG, Chatzimeletiou K, Salem M, Roshdy S, Grimbizis G, Tarlatzis BC, Kolibianakis EM. Testicular versus ejaculated spermatozoa for ICSI in patients without azoospermia: A systematic review. Reprod Biomed Online 2018;37: 573-580.

Kolibianakis EM, Griesinger G, Venetis CA. GnRH antagonists vs. long GnRH agonists in IVF: significant flaws in a meta-analysis lead to invalid conclusions. Hum Reprod Update 2018;24: 242-243.

Lainas GT, Lainas TG, Venetis CA, Sfontouris IA, Zorzovilis IZ, Alexopoulou E, Tarlatzis BC, Kolibianakis EM. Ultrasound and hematological changes during early luteal phase in women at high risk for developing ovarian hyperstimulation syndrome. Ultrasound Obstet Gynecol 2018;51: 126-133.

Sfontouris I, Lainas G, Lainas T, Venetis C, Makris A, Tarlatzis B, Kolibianakis E. OC05: Ultrasound and hematological early-luteal-phase predictors of severe ovarian hyperstimulation syndrome in high-risk patients following triggering of final oocyte maturation with human chorionic gonadotropin. Ultrasound Obstet Gynecol 2018;52: 556.

Sfontouris IA, Lainas GT, Lainas TG, Faros E, Banti M, Kardara K, Anagnostopoulou K, Kontos H, Petsas GK, Kolibianakis EM. Complex chromosomal aberrations in a fetus originating from oocytes with smooth endoplasmic reticulum (SER) aggregates. Syst Biol Reprod Med 2018;64: 283-290.

Venetis CA, Mol BW, Kolibianakis EM. Low as well as high serum P4 levels in the early and mid-luteal phase reduce the chance of a live birth following IVF treatment with fresh embryo transfer: where is the evidence? Hum Reprod 2018;33: 2312-2313.

Awaga HA, Lymperi S, Bosdou JK, Makedos A, Mitsoli A, Bazioti MG, Savvaidou D, Goulis DG, Chatzimeletiou K, Salem MN, Kolibianakis EM. Addition of procyanidine to semen preserves progressive sperm motility up to three hours of incubation. Reprod Biol 2019;19: 255-260.

Bosdou JK, Konstantinidou E, Anagnostis P, Kolibianakis EM, Goulis DG. Vitamin D and Obesity: Two Interacting Players in the Field of Infertility. Nutrients 2019;11.

Bosdou JK, Venetis CA, Tarlatzis BC, Grimbizis GF, Kolibianakis EM. Higher probability of live-birth in high, but not normal, responders after first frozen-embryo transfer in a freeze-only cycle strategy compared to fresh-embryo transfer: a meta-analysis. Hum Reprod 2019;34: 491-505.

Chatzimeletiou K, Vanderzwalmen P, Panagiotidis Y, Papatheodorou A, Karagiannidis A, Kolibianakis E, Grimbizis G, Prapas N, Prapas Y, Tarlatzis BC. Spindle and chromosome configuration analysis of human biopsied versus non-biopsied embryos by confocal laser scanning microscopy following vitrification. Zygote 2019;27: 153-159.

Kalaitzopoulos DR, Lempesis IG, Athanasaki F, Schizas D, Samartzis EP, Kolibianakis EM, Goulis DG. Association between vitamin D and endometriosis: a systematic review. Hormones (Athens) 2019.

Lainas GT, Lainas TG, Sfontouris IA, Chatzimeletiou K, Venetis CA, Bosdou JK, Tarlatzis BC, Grimbizis GF, Kolibianakis EM. Is oocyte maturation rate associated with triptorelin dose used for triggering final oocyte maturation in patients at high risk for severe ovarian hyperstimulation syndrome? Hum Reprod 2019;34: 1770-1777.

Lainas GT, Lainas TG, Sfontouris IA, Venetis CA, Bosdou JK, Chatzimeletiou A, Grimbizis GF, Tarlatzis BC, Kolibianakis EM. Association between body mass index and oocyte maturation in patients triggered with GnRH agonist who are at high risk for severe ovarian hyperstimulation syndrome: an observational cohort study. Reprod Biomed Online 2019.

Mintziori G, Veneti S, Kolibianakis EM, Grimbizis GF, Goulis DG. Egg freezing and late motherhood. Maturitas 2019;125: 1-4.

Vermey BG, Buchanan A, Chambers GM, Kolibianakis EM, Bosdou J, Chapman MG, Venetis CA. Are singleton pregnancies after assisted reproduction technology (ART) associated with a higher risk of placental anomalies compared with non-ART singleton pregnancies? A systematic review and meta-analysis. BJOG 2019;126: 209-218.

Ovarian Stimulation T, Bosch E, Broer S, Griesinger G, Grynberg M, Humaidan P, Kolibianakis E, Kunicki M, La Marca A, Lainas G et al. ESHRE guideline: ovarian stimulation for IVF/ICSI(dagger). Hum Reprod Open 2020;2020: hoaa009.

Στρατής Κολυμπιανάκης

Υπογονιμότητα - Εξωσωματική Γονιμοποίηση

Στρατής Κολυμπιανάκης

MD MSc (Res) MSc (HCM) PhD

Καθηγητής Μαιευτικής Γυναικολογίας και Υποβοηθούμενης Αναπαραγωγής

Ιατρική Σχολή, Αριστοτέλειο Πανεπιστήμιο Θεσσαλονίκης

Δημοσιεύσεις

Διεθνή περιοδικά υπογονιμότητας

Ελληνικός Tύπος

Σύγχρονη αντιμετώπιση της γυναικείας υπογονιμότητας, Χρέος ζωής 2016

Παιδί μετά τα 40, με τη βοήθεια αυξητικής ορμόνης. In vitro, Σεπτέμβριος 2014

Γυναικεία υπογονιμότητα: όταν η λύση δεν έιναι η εξωσωματική. Forma 2010

Εξωσωματική γονιμοποίηση: τώρα πιο ασφαλής και φιλική. Χρέος ζωής, 2009

Εξωσωματική γονιμοποίηση. Χρέος ζωής

Εκτίμηση και αξιολόγηση των κλινικών μελετών. Ferlity news.gr 2006

Διεθνής τύπος

More facts, less opinion ‘We have to be critical in evaluating research before accepting its conclusions’

Recurrent implantation failure on Lisbon agenda

Making OHSS a complication of the past

GnRH triggering for elimination of OHSS

IVF without the threat of OHSS Campus meeting on GnRH agonist triggering

Agonist triggering next on the agenda

Record turnout for London precongress course